HYKU Biosciences is a startup. Brouky records 1 investor associated with the company.
HYKU Biosciences is a biotechnology company listed in the Novartis Venture Fund portfolio. Novartis Venture Fund lists it among biotechnology and biopharma life-science companies developing therapeutics and platform technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.